Bionano Genomics Inc (BNGO)

NASDAQ
Currency in USD
Disclaimer
2.9200
-0.0600
(-2.01%)
Closed
3.0000
+0.0800
(+2.7397%)
After Hours
Real-time Data
Trading near 52-week Low
Day's Range
2.9100
3.0400
52 wk Range
2.9100
30.1000
Volume
430,468
Prev. Close
2.98
Open
3
Day's Range
2.91-3.04
52 wk Range
2.91-30.1
Volume
430,468
Average Vol. (3m)
1,075,129
1-Year Change
-84.3%
Shares Outstanding
35,348,440
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
20.2000
Upside +591.7808%

People Also Watch

5.02
CHPT
-1.38%
10.87
M
+0.28%
58.24
FTNT
-0.92%
0.2540
TTOO
-12.35%
1.6600
TUP
-4.60%
How do you feel today about BNGO?
Vote to see community's results!
or

Bionano Genomics Inc Company Profile

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sells the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Income Statement